EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
Last month the members of the European Association of Hospital Pharmacists (EAHP) came together for their annual General Assembly. Like every year, EAHP’s 35 member associations discussed and approved new position papers developed for the profession. The Position Paper on Advanced Therapy Medicinal Products was one of three that was adopted by EAHP’s General Assembly.
Advanced therapy medicinal products (ATMPs) are innovative and complex medicines used to treat a variety of human health issues. Areas of application include, but are not limited to, cancers, neurodegenerative diseases, inherited diseases and autoimmune diseases. In particular, patients suffering from severe, rare or chronic diseases might benefit in the future from the growing use of ATMPs. Hospital pharmacists are responsible for ensuring the safe and effective use of medicines. This expertise of the pharmacy workforce should be a central component to adequate delivery of ATMPs within hospitals. Their participation is not only invaluable in clinical trials for ATMPs where they are responsible for the correct receipt, storage, distribution and control of the clinical trial drug, but also for routine clinical practice.
Since the use of ATMPs for the treatment of disease and injury is growing, EAHP adopted a position paper on this topic that outlines the roles and responsibilities of hospital pharmacists in the handling of ATMPs, addresses their education and training in relation to these products and provides insights on the assessment of ATMPs and pharmacoeconomics.
In its position paper, EAHP
EAHP’s Position Paper on Advanced Therapy Medicinal Products is available HERE
Last month, EAHP joined the newly established HERA Civil Society Forum as one of its members. The Civil Society Forum was set up to provide regular input on the views and opinions of civil society stakeholders to HERA. EAHP is among the 23 organisations that were selected to represent patients, consumers and healthcare professionals.
The first virtual meeting at the end of June focused on gathering the views of participants on the lessons learned from the COVID-19 crisis and the role of HERA in the response, the state of preparedness of the EU for future health emergencies and the priorities of HERA for 2023.
The Civil Society Forum is part of HERA’s governance structure that also includes an Advisory Forum, bringing together HERA and the technically competent bodies in the Member States, and the Joint Industrial Cooperation Forum (JICF) that was set up as a subgroup of HERA’s Advisory Forum to support collaboration with health-related industrial ecosystems in the area of preparedness and response to health crises.
Learn more about HERA’s forums HERE
Both EAHP’s SIG focused on the Use of Prefilled Syringes in Intensive Care Units and Operating Theatres (financially supported by BD) and EAHP’s SIG on Automated Medication Management (financially supported by Omnicell) are currently gathering feedback with the help of surveys to inform their work. The survey linked to automation will remain open until the end of July, while comments on prefilled syringes can be submitted until the end of August.
The activity of EAHP’s SIG on Automated Medication Management focuses on the benefits of automation, particularly around the medication preparation/ compounding/ dispensing process, and how technology best meets the needs of different hospital pharmacy workflows. Hospital pharmacists are encouraged to share their views and opinions on the current and future use of automated medication management solutions. The short survey (10 to 15 minutes) will remain open until the 31st of July. Participation is voluntary and the SIG is looking for one response per hospital pharmacy. Six different language versions (English, French, Italian, Polish, Slovak and Spanish) are available.
EAHP’s SIG focused on the Use of Prefilled Syringes in Intensive Care Units and Operating Theatres has prepared two surveys targeting on one hand professional associations and on the other hand health professionals and managers. Participation is completely voluntary. It should take approximately 10 to 15 minutes to complete the survey. Feedback can be shared until the 31st of August 2022. The survey for professional associations is available in English. The survey for individual health professionals and managers can be completed in eight different languages (English, French, German, Hungarian, Italian, Serbian, Spanish and Turkish).
Access the survey on automated medication management HERE
Access the survey for individuals on prefilled syringes HERE
Access the survey on prefilled syringes targeting professional associations HERE
As part of the Trio Presidency of France, the Czech Republic, and Sweden, the Czech Republic took over the EU’s Council Presidency on the 1st of July. Five closely linked areas will be the focus of the presidency that come together under the slogan “Europe as a task: Rethink, Rebuild, Repower”.
In the field of health, the Czech Presidency plans to continue the fight against the COVID-19 pandemic with a specific focus on improving the EU’s preparedness for further health crises. Other health priorities include cancer, the proposal for a Regulation on the European Health Data Space, vaccination and rare diseases.
Learn more about the Czech Council Presidency HERE
In the second half of June, the European Commission launched the Healthier together – EU Non-Communicable Diseases Initiative (EU NCD Initiative) which aims at supporting Member States to reduce the burden of NCDs in Europe. Key aims include addressing the leading causes of avoidable premature death in Europe and improving citizens’ health and well-being.
The Healthier Together Initiative on NCDs will concentrate on five key strands:
The guidance document that was published includes recommendations to address risk factors such as unhealthy lifestyles. To implement action in the field of NCDs, 30% of the EU4Health budget is allocated to health promotion and disease prevention.
Learn more about the EU NCD Initiative HERE
In case you missed the news, on the 26th of May the Regulation (EU) 2017/746 on in vitro diagnostic medical devices entered into application. This means that all new devices, along with those undergoing a significant change, as well as all class A non-sterile devices, must comply with the new rules. Transitional periods are in place for devices lawfully placed on the market under Directive 98/79/EC (except class A non-sterile) until 26 May 2025 or 26 May 2027, depending on the risk class.
More information can be found HERE
The July edition of the European Journal of Hospital Pharmacy (EJHP) is available. It contains several original research articles, a systematic review, two case reports, one hands-on medicines information segment and the EU and EAHP news section. The editorial focuses on randomised controlled trials. The effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients, haemorrhagic complications in patients with renal insufficiency during treatment or prophylaxis with dalteparin and long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease are some of the topics covered by the original research articles.
Read the July issue HERE
Did you know that EAHP’s Statement website contains an evidence map that helps you with the identification of Good Practice Initiatives (GPIs), case studies and the Statement Implementation Learning Collaborative Centres (SILCCs)? Have a look at the map and explore what your colleagues around Europe are doing: /hospital-pharmacy-practice/evidence-map
